XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating Activities    
Net income (loss) $ (5,219) $ 99,785
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Gain on bargain purchase 0 (74,408)
Depreciation and amortization, net of accretion 20,409 16,320
(Increase) decrease in cash surrender value of BOLI 949 230
Net investment (gains) losses 37,390 (19,682)
Share-based compensation 2,392 2,184
Deferred income tax expense (benefit) (3,408) (1,813)
Policy acquisition costs, net of amortization (net deferral) (4,173) (4,906)
Equity in (earnings) loss of unconsolidated subsidiaries (12,799) (18,715)
Distributed earnings from unconsolidated subsidiaries 19,240 13,355
Other, net (507) 198
Change in:    
Premiums receivable (3,955) 23,711
Reinsurance related assets and liabilities (15,899) (9,213)
Other assets 10,756 10,827
Reserve for losses and loss adjustment expenses (7,078) 22,207
Unearned premiums 16,610 (41,294)
Other liabilities (58,379) 12,229
Net cash provided (used) by operating activities (3,671) 31,015
Purchases of:    
Fixed maturities, available-for-sale (340,746) (765,518)
Equity investments (30,266) (119,661)
Other investments (17,136) (48,521)
Investment in unconsolidated subsidiaries (20,129) (9,476)
Proceeds from sales or maturities of:    
Fixed maturities, available-for-sale 308,285 562,789
Equity investments 74,700 384,989
Other investments 10,930 23,207
Net sales or (purchases) of fixed maturities, trading (2,449) 2,123
Return of invested capital from unconsolidated subsidiaries 27,352 37,420
Net sales or maturities (purchases) of short-term investments (109,566) 46,987
Unsettled security transactions, net change 11,507 39,416
Purchases of capital assets (2,232) (3,108)
Cash paid for acquisitions, net of cash acquired 0 (221,576)
Other (1,363) 0
Net cash provided (used) by investing activities (91,113) (70,929)
Financing Activities    
Borrowings under Revolving Credit Agreement 0 15,000
Repayments of Mortgage Loans 0 (16,368)
Dividends to shareholders (8,080) (5,376)
Capital contribution received from (return of capital to) external segregated portfolio cell participants (7,117) (8,064)
Other 1,211 (264)
Net cash provided (used) by financing activities (13,986) (15,072)
Increase (decrease) in cash and cash equivalents (108,770) (54,986)
Cash and cash equivalents at beginning of period 143,602 215,782
Cash and cash equivalents at end of period 34,832 160,796
Significant Non-Cash Transactions    
Dividends declared and not yet paid 0 2,700
Operating ROU assets obtained in exchange for operating lease liabilities 0 5,275
Fair value of Contribution Certificates issued in NORCAL acquisition 0 174,999
Fair value of contingent consideration in NORCAL acquisition $ 0 $ 24,000